EVERY IMMUNE SYSTEM HAS A STORY TO TELL. THE KEY IS KNOWING HOW TO LISTEN.
Live / Registered — Registered (as of 09 Jul 2024)
What this means for you
Registered since 09 Jul 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90459471
- Registration number
- 7443900
- Mark type
- Stylized text
- Filed
- 11 Jan 2021
- Published for opposition
- 07 Sept 2021
- Registered
- 09 Jul 2024
- Attorney of record
- Hoang-chi Truong
Goods and services
- Class 042 — Scientific and technological services: Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services
Owner
- Adaptive Biotechnologies Corp., Seattle, WA, US
- Adaptive Biotechnologies Corp., Seattle, WA, US
- Adaptive Biotechnologies Corp., Seattle, WA, US
Prosecution history
- 09 Jul 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Jul 2024 — REGISTERED-PRINCIPAL REGISTER
- 31 May 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 May 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 May 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 28 May 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Apr 2024 — TEAS STATEMENT OF USE RECEIVED
- 04 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Nov 2023 — SOU EXTENSION 4 GRANTED
- 02 Nov 2023 — SOU EXTENSION 4 FILED
- 02 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 03 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 May 2023 — SOU EXTENSION 3 GRANTED
- 01 May 2023 — SOU EXTENSION 3 FILED
- 01 May 2023 — SOU TEAS EXTENSION RECEIVED